Large-scale testing (Phase 3)UnknownNCT02070211
What this trial is testing
Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Who this might be right for
22q11 Deletion Syndrome
Bambino Gesù Hospital and Research Institute 80